Densmore Laboratory expert in Ophthalmology

Since its creation in 1946 by Dr Robert DENSMORE, the laboratory has been guided by the permanent idea of improving patient care and quality of life . The core business of our laboratory is the development and marketing of innovative formulas. Our vocation is to participate in scientific progress and the evolution of medical practices.

Create specific solutions that meet the highest healthcare requirements.
Select molecules that combine efficacy and safety to improve patient benefit.
Involve healthcare professionals in our innovation process.

The ocular surface plays a fundamental role in the comfort and sight of patients . Densmore Laboratory develops innovative formulas to improve their care.

In order to preserve the quality of life of patients, the Densmore laboratory teams are working to identify effective molecules and to develop ophthalmic solutions.

To fight against glaucoma , the second cause of blindness in developed countries and a real public health issue, the Densmore Laboratory is participating in the study of new therapeutic avenues with a view to preserving the visual health of patients.

The Densmore lab is studying different neuroprotective agents. They promote repair of the integrity of damaged cell membranes in degenerative ophthalmic pathologies such as glaucoma.

While retinal aging cannot be prevented, it is nevertheless possible to prevent its consequences. This is one of the major challenges of the Densmore Laboratory.

Food supplements can play a protective role in certain retinal damage. To compensate for food deficits and effectively support vision, Laboratoire Densmore is developing formulas rich in nutrients selected for their properties and the reliability of their sourcing.